1. Rezaeeyan H, Jaseb K, Alghasi A, Asnafi AA, Saki N. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis. 2017; 28:617–622.
Article
2. Morgan DS, Afifi RA, El-Hoseiny SM, Amin DG, Ibrahim SYG. The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children. Hematology. 2017; 1–5.
Article
3. El Sissy MH, El Sissy AH, Elanwary S. Tumor necrosis factor-α-308G/A gene polymorphism in Egyptian children with immune thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2014; 25:458–463.
Article
4. Suzuki T, Matsushima M, Shirakura K, et al. Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Digestion. 2008; 77:73–78.
Article
5. Lee YH, Bae SC. Association between interferon-γ+874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus. 2016; 25:710–718.
Article
6. Yadav DK, Tripathi AK, Gupta D, et al. Interleukin-1B (
IL-1B-31 and
IL-1B-511) and interleukin-1 receptor antagonist (
IL-1Ra) gene polymorphisms in primary immune thrombocytopenia. Blood Res. 2017; 52:264–269.
Article
7. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996; 87:2095–2147.
Article
8. Schneider BG, Camargo MC, Ryckman KK, et al. Cytokine polymorphisms and gastric cancer risk: an evolving view. Cancer Biol Ther. 2008; 7:157–162.
Article
9. Wu KH, Peng CT, Li TC, Wan L, Tsai CH, Tsai FJ. Interleukin-1beta exon 5 and interleukin-1 receptor antagonist in children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol. 2007; 29:305–308.
Article
10. Satoh T, Pandey JP, Okazaki Y, et al. Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens. 2009; 73:353–357.
Article